Embed Size (px)
Citation preview
![Page 1: } u µ ] } v } ( Z ] o W ] } v & µ Ç U î ì î ì µ v W ð } ( W K U î ì í ï ...€¦ · } u µ ] } v } ( Z ] o W ] } v & µ Ç U î ì î ì µ v W ð } ( W K U î ì í](https://reader033.pdfslide.net/reader033/viewer/2022051411/603f8fa91e10e45280523beb/html5/thumbnails/1.jpg)
Computatation of Retail Price based on February, 2020 Data under Para 4 of DPCO, 2013Number of Companies cosisting of Market Share of 1% & Above 9Sum of MAT value considered for price calculation (in Lakhs) 828.48 Sum of PTR per unit considered for price calculation 29.28
Number of Packs considered 9
Average PTR 3.25Add : 16% Retailer Margin 0.52Retail Price (without local taxes) 3.77
% Reduction with compared to Highest Price 67.95%
Minimumum Price (Rs.) 0.90Maximum Price (Rs.) 10.14Average of all considered (Rs.) 3.25Retail Price (Rs.) 3.77
TOTAL MAT 84,494,195 100%S.No. पैक ववरण
Pack DescriptionछापBRAND
कंपनीCompany
Strength Pack Size Unit PTR(Rs.) MAT(Rs.) SKU wise MAT %
Brandwise MAT (ignoring O% MAT)
Qualify ( Y/N)Y=YesN=No
Price per Unit (Rs.)
Price per Unit (Rs.) Considered
1 AFLOX D 0.3/0.1 % DROPS 5 ML AFLOX D APPSAMY OCULAR DEVICES 0.3/0.1 % 5 ML 12.1 273629.4 0.32% 0.32% N 2.42
2 AMOFLOX D 0.3/0.1 % EYE DROPS 5 ML AMOFLOX D PFIZER LTD 0.3/0.1 % 5 ML 8.79 98166.72 0.12% 0.12% N 1.76
3 BIOFF D 0.3/0.1 % EYE DROPS 10 ML BIOFF D ZYDUS CADILA - ZHL 0.3/0.1 % 10 ML 6.95 114147.65 0.14% 0.14% N 0.70
4 CANDIBIOTIC AB 0.3/0.1 % EAR DROPS 5 ML CANDIBIOTIC AB GLENMARK PHARMACEUTICALS LTD. 0.3/0.1 % 5 ML 50.71 15515282.31 18.36% 18.36% Y 10.14 10.14
5 FESTIVE D 0.3/0.1 % DROPS 10 ML FESTIVE D LABORATE PHARMACEUTICAL LTD 0.3/0.1 % 10 ML 9 1551708 1.84% 1.84% Y 0.90 0.90
6 OFAXD X 0.3/0.1 % DROPS 5 ML OFAXD X OPTHO REMEDIES PVT.LTD 0.3/0.1 % 5 ML 8.31 24.93 0.00% 0.00% N 1.66
7 OFC DX 0.3/0.1 % DROPS 5 ML OFC DX JAWA LABORATORIES 0.3/0.1 % 5 ML 11.58 871931.3 1.03% 1.03% Y 2.32 2.32
8 OFEN DX 0.3/0.1 % DROPS 5 ML OFEN DX WENS PHARMA PVT LTD 0.3/0.1 % 5 ML 18.7 822.8 0.00% 0.00% N 3.74
9 OFLACIN DX 0.3/0.1 % EYE DROPS 5 ML OFLACIN DX MICRO LABS LTD 0.3/0.1 % 5 ML 8.93 2321674.98 2.75% 2.75% Y 1.79 1.79
10 OFLO DM 0.3/0.1 % EYE DROPS 10 ML OFLO DM SUNWAYS (INDIA) PVT LTD 0.3/0.1 % 10 ML 10.71 2844820 3.37% 3.37% Y 1.07 1.07
11 OFLOBE D 0.3/0.1 % EYE DROPS 5 ML OFLOBE D SAPIENT 0.3/0.1 % 5 ML 6.8 54814.8 0.06% 0.06% N 1.36
12 OFLOX D 0.3/0.1 % EYE DROPS 10 ML OFLOX D CIPLA LTD. 0.3/0.1 % 10 ML 12.1 25433107.7 30.10% 30.10% Y 1.21 1.21
13 OFLOXAMAC D 0.3/0.1 % EYE DROPS 5 ML OFLOXAMAC D TORQUE PHARMACEUTICALS PVT LTD 0.3/0.1 % 5 ML 10.97 444712.83 0.53% 0.53% N 2.19
14 OFLOZEN D 0.3/0.1 % DROPS 5 ML OFLOZEN D EXELTIS 0.3/0.1 % 5 ML 9.94 656145.14 0.78% 0.78% N 1.99
15 OMEFLOX DX 0.3/0.1 % DROPS 5 ML OMEFLOX DX ENTOD PHARMACEUTICALS LTD 0.3/0.1 % 5 ML 8.66 441.66 0.00% 0.00% N 1.73
16 OTODAC DX 0.3/0.1 % EAR DROPS 5 ML OTODAC DX ZYDUS CADILA - ZHL 0.3/0.1 % 5 ML 46.43 16244603.39 19.23% 19.23% Y 9.29 9.29
17 OXOP D 0.3/0.1 % EYE DROPS 10 ML OXOP D CENTAUR PHARMACEUTICALS PVT.LTD 0.3/0.1 % 10 ML 9.19 4481754.23 5.30% 5.30% Y 0.92 0.92
18 ZENFLOX D 0.3/0.1 % DROPS 5 ML ZENFLOX D MANKIND PHARMACEUTICALS LTD. 0.3/0.1 % 5 ML 6.16 1201.2 0.00% 0.00% N 1.23
19 ZO D 0.3/0.1 % EYE DROPS 5 ML ZO D FDC LTD. 0.3/0.1 % 5 ML 8.21 13582632.21 16.08% 16.08% Y 1.64 1.64
20 ZYNOFF D 0.3/0.1 % EYE DROPS 5 ML ZYNOFF D NRI VISION CARE 0.3/0.1 % 5 ML 7.25 2573.75 0.00% 0.00% N 1.45
Rs. Per mlWorked out Retail Price 3.77 Excluding GSTClaimed Retail Price 6.50Proposed retail Price 3.77 Excluding GST
Each ml eye/ ear drops contain Ofloxacin IP 0.3% w/v + Dexamethasone Sodium Phosphate IP 0.1% w/v for M/s. Skymap Healthcare Pvt. Ltd. (manufacturer/ importer) and M/s Albert David Ltd. (marketers)
M3
![Page 2: } u µ ] } v } ( Z ] o W ] } v & µ Ç U î ì î ì µ v W ð } ( W K U î ì í ï ...€¦ · } u µ ] } v } ( Z ] o W ] } v & µ Ç U î ì î ì µ v W ð } ( W K U î ì í](https://reader033.pdfslide.net/reader033/viewer/2022051411/603f8fa91e10e45280523beb/html5/thumbnails/2.jpg)
Computatation of Retail Price based on February, 2020 Data under Para 4 of DPCO, 2013Number of Companies cosisting of Market Share of 1% & Above 4Sum of MAT value considered for price calculation (in Lakhs) 1,083.02 Sum of PTR per unit considered for price calculation 20.42
Number of Packs considered 4
Average PTR 5.11Add : 16% Retailer Margin 0.82Retail Price (without local taxes) 5.93
% Reduction with compared to Highest Price 17.71%
Minimumum Price (Rs.) 4.21Maximum Price (Rs.) 6.21Average of all considered (Rs.) 5.11Retail Price (Rs.) 5.93
TOTAL MAT 108,677,456 100%S.No. पैक ववरण
Pack DescriptionछापBRAND
कंपनीCompany
Strength Pack Size Unit PTR(Rs.) MAT(Rs.) SKU wise MAT %
Brandwise MAT (ignoring O% MAT)
Qualify ( Y/N)Y=YesN=No
Price per Unit (Rs.)
Price per Unit (Rs.) Considered
1 BINGO 1/2 % EAR DROPS 15 ML BINGO NEXTGEN HEALTH CARE PVT.LTD 1/2 % 15 ML 34.3 1646.2 0.00% 0.00% N 2.29
2 CANDID 1/2 % EAR DROPS 10 ML CANDID GLENMARK PHARMACEUTICALS LTD. 1/2 % 10 ML 53.57 77695747.19 71.49% 71.49% Y 5.36 5.36
3 CLOTRIN 1 % EAR DROPS 10 ML CLOTRIN NULIFE PHARMACEUTICALS 1/2 % 10 ML 62.14 15093681.72 13.89% 13.89% Y 6.21 6.21
4 OLEX AF 1/2 % EAR DROPS 10 ML OLEX AF NAVIL LABORATORIES 1/2 % 10 ML 42.86 12557.98 0.01% 0.01% N 4.29
5 OTO SAP LC 1/2 % EAR DROPS 5 ML OTO SAP LC SAPIENT 1/2 % 5 ML 50 333350 0.31% 0.31% N 10.00
6 OTODAC-CL 1/2 % EAR DROPS 10 ML OTODAC-CL ZYDUS CADILA - ZHL 1/2 % 10 ML 46.43 12691640.5 11.68% 11.68% Y 4.64 4.64
7 RAYSTAT 1/2 % EYE/EAR DROPS 10 ML RAYSTAT KAIZEN PHARMA 1/2 % 10 ML 34.29 27432.73 0.03% 0.03% N 3.43
8 TRIBEN 1 % EAR DROPS 10 ML TRIBEN JENBURKT PHARMACEUTICALS LTD 1/2 % 10 ML 42.14 2821399.42 2.60% 2.60% Y 4.21 4.21
Rs. Per mlWorked out Retail Price 5.93 Excluding GSTClaimed Retail Price 13.50Proposed retail Price 5.93 Excluding GST
Each ml ear drops contain Clotrimazole IP 1.0% w/v + Lignocaine Hydrochloride IP 2.0% w/v for M/s. Skymap Healthcare Pvt. Ltd. (manufacturer and marketers)
M3
![Page 3: } u µ ] } v } ( Z ] o W ] } v & µ Ç U î ì î ì µ v W ð } ( W K U î ì í ï ...€¦ · } u µ ] } v } ( Z ] o W ] } v & µ Ç U î ì î ì µ v W ð } ( W K U î ì í](https://reader033.pdfslide.net/reader033/viewer/2022051411/603f8fa91e10e45280523beb/html5/thumbnails/3.jpg)
Computatation of Retail Price based on March, 2020 Data under Para 4 of DPCO, 2013
Number of Companies cosisting of Market Share of 1% & Above 5Sum of MAT value considered for price calculation (in Lakhs) 4,189.35
Sum of PTR per unit considered for price calculation 28.44Number of Packs considered 6
Average PTR 4.74Add : 16% Retailer Margin 0.76Retail Price (without local taxes) 5.50
% Reduction with compared to Highest Price 24.16%
Minimumum Price (Rs.) 4.18Maximum Price (Rs.) 6.25Average of all considered (Rs.) 4.74Retail Price (Rs.) 5.5
TOTAL MAT 420,474,675 100%S.No. पैक ववरण
Pack DescriptionछापBRAND
कंपनीCompany
Strength Pack Size Unit PTR (Rs.) MAT (Rs.) SKU wise MAT %
Brandwise MAT (ignoring O% MAT)
Qualify ( Y/N)Y=YesN=No
Price per Unit (Rs.)
Price per Unit (Rs.) Considered
1 ATOREC GOLD 75/20/75 MG CAPSULE 10 ATOREC GOLD EMCURE PHARMACEUTICALS LTD 75/20/75 MG 10 Capsule 42.14 240998.66 0.06% 0.06% N 4.21
2 ATORLIP GOLD 75/20/75 MG CAPSULE 10 ATORLIP GOLD CIPLA LTD. 75/20/75 MG 10 Capsule 42.16 531468.96 0.13% 0.13% N 4.22
3 ATORMAC GOLD 75/20/75 MG CAPSULE 15 ATORMAC GOLD MACLEODS PHARMACEUTICALS PVT.LTD 75/20/75 MG 15 Capsule 63.64 15103651.82 3.59% 3.59% Y 4.24 4.24
4 ATORVA GOLD 75/20/75 MG CAPSULE 15 ATORVA GOLD ZYDUS CADILA - ZHL 75/20/75 MG 15 Capsule 62.64 9825334.56 2.34% 2.34% Y 4.18 4.18
5 AZTOGOLD 75/20/75 MG CAPSULE 10 AZTOGOLD UNIMED TECHNOLOGIES LIMITED 75/20/75 MG 10 Capsule 50.54 51053481 12.14% 12.14% Y 5.05 5.05
6 CLAVIX GOLD 75/20/75 MG CAPSULE 15 CLAVIX GOLD INTAS PHARMACEUTICALS LTD 75/20/75 MG 15 Capsule 65.36 51136486.04 12.16% 12.16% Y 4.36 4.36
7 DEPLATT CV 75/20/75 MG CAPSULE 10 DEPLATT CV TORRENT PHARMACEUTICALS LTD. 75/20/75 MG 10 Capsule 62.5 277435437.5 65.98% 65.98% Y 6.25 6.25
8 LIPICURE GOLD 75/20/75 MG CAPSULE 15 LIPICURE GOLD INTAS PHARMACEUTICALS LTD 75/20/75 MG 15 Capsule 65.36 14380245 3.42% 3.42% Y 4.36 4.36
9 ROZFIRST GOLD 75/20/75 MG CAPSULE 10 ROZFIRST GOLD SINSAN PHARMACEUTICALS 75/20/75 MG 10 Capsule 114.29 767571.64 0.18% 0.18% N 11.43
Rs. per capsuleWorked out Retail Price 5.50 Excluding GSTClaimed Retail Price 6.71 Excluding GSTProposed retail Price 5.50 Excluding GST
Each hard gelatine capsule contains Atorvastatin calcium IP eq. to Atorvastatin (as film coated tablet form) 20mg +Aspirin IP (as enteric coated tablet form) 75 mg +Clopidogrel Bisulphate IP eq. to Clopidogrel(as film coated tablet form) 75 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (manufacturer/ importer) and M/s Dr. Reddy's Laboratories Ltd. (marketers)
M3
![GREN ENERGY CAMP ESTATE 2018 per telefoni · r v Ì ] v ] v } ] î ] µ } ] } P v ] P µ } ] î ì p î ð P Ì Ì ]](https://img.pdfslide.net/doc/110x75/5c66624809d3f20f218c2d7d/gren-energy-camp-estate-2018-per-telefoni-r-v-i-v-v-i-p.jpg)
![K ( Z µ } v h v ] } v À ] ] } v ^ ( Ç P v Ç...v } o ] v v µ o ] À ] Ç Z } î ì í õ / í D v P u v } ] ] } v /^/KE E £ ì î r î ì î ì } ( î ñ : µ v î ì î ì KWd/E](https://img.pdfslide.net/doc/110x75/60b429c15de3153d232c3393/k-z-v-h-v-v-v-p-v-v-o-v-v-o-z.jpg)
![v } o ] À } r î ì î ì î í d ] µ o µ } u ] } µ ] } · E Ñ v ] } u ] ] }E } u v } o ] À } r î ì î ì î í d ] µ o µ } u ] } µ ] }](https://img.pdfslide.net/doc/110x75/5fdb63fd5fd4e24cbd7bf158/v-o-r-d-o-u-e-v-u-e.jpg)
![SAIF Newsletter January 2020 edit cvsaif.org.za/downloads/newsletters/January-2020.pdf · ^ /& E Á o : v µ Ç î ì î ì í ^ } µ Z v ( ] v ^ /& E Á o : v µ Ç î ì î ì î](https://img.pdfslide.net/doc/110x75/5f9f8a18a0ffe40078069d92/saif-newsletter-january-2020-edit-e-o-v-.jpg)
![Kelpie JTO 2021-2025 valmis - SBCAK · 2020. 3. 7. · í î d µ o µ l l } ð X s µ } ] v î ì í ì r î ì í õ i o } µ l v µ v ] u u ] v l Ç Ç î ì µ }](https://img.pdfslide.net/doc/110x75/5fd08ceac48dc661630ff0bc/kelpie-jto-2021-2025-valmis-2020-3-7-d-o-l-l-x-s-.jpg)
![IMTA President’s Message î ì í î r î ì í ï DdE ^ µ v } u ...IMTA President’s Message î ì í î r î ì í ï DdE ^ µ v } u } ] } v } u } v](https://img.pdfslide.net/doc/110x75/5f6031c10367a41fcc372045/imta-presidentas-message-r-dde-v-u-imta-presidentas.jpg)
![K ( u ] & } r: µ v ] } î ì î ì u µ ] µ D Æ ] } } ( µ i u ...escolares.ccm.itesm.mx/inscripciones/OfertaSemestralCCM.pdfï ì î ñ í/ v } o À ] } ( ] } v o í ò W ì ì](https://img.pdfslide.net/doc/110x75/5e8e3b9b3f5a6363420fce4c/k-u-r-v-u-d-i-u-.jpg)
![µ v W · o ] î ì í ó ~W } v W · o ] } W W } i µ ] À }ì ï ì î ì î ì ï ó õ o o í õ r E · u } î ì ì r Æ ð î Ç ð î r & X s ] o P U D µ v í î U ì ï í](https://img.pdfslide.net/doc/110x75/5e3ca3df330b0c5d85582dfa/-v-w-o-w-v-w-o-w-w-i-.jpg)
![^ h Z î ì î ì r , l ^ h Z o µ î ì î ì r , W v µ d u ] v o ... · ^ h Z î ì î ì r , l ^ h Z o µ î ì î ì r , W v µ d u ] v o v D } µ o d Z u d u ] v Z ( v ] v v](https://img.pdfslide.net/doc/110x75/5ffc1672e489f702bc4734b5/-h-z-r-l-h-z-o-r-w-v-d-u-v-o-h-z-.jpg)
![} µ µ ^ d } o W ] } E u } } µ µ E u DZW ~Z X ZW ~Z X '^d ... · ,hE' D D À o ,Y ds ð í ds } µ µ í î ð X ì ì î ð X ì ì ð X ï î î ô X ï î ds ds î ds Z ] µ](https://img.pdfslide.net/doc/110x75/5e68518d8a82b539fb3568b1/-d-o-w-e-u-e-u-dzw-z-x-zw-z-x-d-he-d-d-o-y.jpg)
![2021 Spring Plant Sale List Rev. 1& µ o o } v } µ u ^h & µ o o } v í õ ì ì } ] Z X & µ o o } v U õ î ô ï í ò ñ ó r î ó ô r ð ì í ì W P î } ( î î î ì î](https://img.pdfslide.net/doc/110x75/60e95edb5f0c0378245d0e85/2021-spring-plant-sale-list-rev-1-o-o-v-u-h-o-o-v-.jpg)
![h^ u y î ì î ì l î í - MGMSAí î l ì ñ l î ì Z µ u v o / v ( } u D v µ o K ( Ç u v D µ v ] o ~ v D ] o o } v d v D Ç î ì í õ l î ì ] ( } v ] ( 9D Ç î ì í](https://img.pdfslide.net/doc/110x75/5edef7acad6a402d666a53f7/h-u-y-l-l-l-z-u-v-o-v-u-d-v-o.jpg)
![^ u v µ u u Z Z À } u E u ^ , µ ] v µ u u W } } W o µ u ( P ] ( · W í ì ì ì ì î v u v Ì ld Æ ] s } } Z } v d } o í î î î ñ í^:sKKZ^ ,Kd E ì ð r ì ñ r î ì](https://img.pdfslide.net/doc/110x75/5e56ba6d8817235b073bc5c5/-u-v-u-u-z-z-u-e-u-v-u-u-w-w-o-u-p-w-.jpg)
![Viewrail-09-2020 Surface Mount Universal Top Report...^ µ ( D } µ v W } rh v ] À o d } ' o o µ d Z } Z } E µ u W s ] Á ] o r ì õ r î ì î ì Z À ì í & î ð U î ì î](https://img.pdfslide.net/doc/110x75/61323d49dfd10f4dd73a523d/viewrail-09-2020-surface-mount-universal-top-report-d-v-w-rh-v.jpg)
![Z µ o } ( Z µ À Ç } v Z µ } ( Z } ] v Á v : µ v î ì U î ì ... · Z µ o } ( Z µ À Ç } v Z µ } ( Z ] } o ] v / v v } v o } ] v Á v : µ v î ì U î ì í ò v u î](https://img.pdfslide.net/doc/110x75/5f0ea78c7e708231d440484c/z-o-z-v-z-z-v-v-v-u-z-o.jpg)
![d Z ^ µ ] d Z ^ µ ( µ o ^ P ] ^ Z Z [ J ( } u , W v ^ µ ... · ð l í l î ì î ì î v v µ o Z Ç ] o î ì í ò W &W' í í ï U E } í î ì í ó W &W' í ì ì U í ò](https://img.pdfslide.net/doc/110x75/5f24c980d069be108e57daf6/d-z-d-z-o-p-z-z-j-u-w-v-l-l-.jpg)
![µ v } ] P } ] } µ ( µ } o o ] v Ed l r ì ð í D ] v ] } & } · 2020. 7. 17. · E µ u } } u o } d ] µ o } } u ] ! Ed DE /^K ldZ î î ô ò õ W î ì ì ô í W î ì ì õ](https://img.pdfslide.net/doc/110x75/610c7639fc16314cfa198452/-v-p-o-o-v-ed-l-r-d-v-2020-7-17.jpg)
![K/^ ' DD E ^dK < D Zz r K/^ î ì í ó - mery-bois.com · s ] } v µ ó l ì î l î ì í ô , µ [ } µ À µ o o [ Æ } ] µ d ] o +](https://img.pdfslide.net/doc/110x75/5ad43f0c7f8b9a0d2d8c1f22/k-dd-e-dk-d-zz-r-k-mery-bois-v-l-l-o-o-d-o-.jpg)
![] u ] À } } u } o ] } } W>W v Ñ ì ï õ l î ì î ì r µ Æ o ...§cao_… · ] ] µ ] } } î ì ] v } D µ v ] _ ] } ] ] µ ] } } ï ] v } D µ v ] _ ] }](https://img.pdfslide.net/doc/110x75/5f5f874e746fe0058f6bd4b3/-u-u-o-ww-v-l-r-o-cao.jpg)
![Análisis Razonado 1Q2020 VF18 · d EE Z t E >/^/^ Z KE K D Z K î ì î ì î / X Z µ u v i µ ] À } > µ ] o ] µ ] u µ } o ] u ] u î ì î ì](https://img.pdfslide.net/doc/110x75/5f08778c7e708231d4222790/anflisis-razonado-1q2020-vf18-d-ee-z-t-e-z-ke-k-d-z-k-.jpg)
![Presentasi unbk2019 (2)W Z^z Z d E D/E/DhD / Ed ì í ì î ì î ì î ì î ì î ì î. v v {hW^ µ v µ l À ~ Z v í ñ u v ] {' v µ v µ l o µ µ Z v P l Ç](https://img.pdfslide.net/doc/110x75/6016e3e029120862776a31b3/presentasi-unbk2019-2-w-zz-z-d-e-dedhd-ed-.jpg)
![µ ] } Z µ u v } ^ o } o µ v } n î ì í ô X î ì í õ · ' µ ] } Z µ u v } ^ o } o µ v } n î ì í ô X î ì í õ. ' µ ] } Z µ u v } ^ o } o µ v } n î ì í ô](https://img.pdfslide.net/doc/110x75/5e4c6d33fb6f6771266d58d5/-z-u-v-o-o-v-n-x-z-u-v.jpg)
![d/WK EEK · v v } ] } v } ] µ } o } o ( ( µ ] o î ì l ì ð l î ì î ì } À À } o o ]](https://img.pdfslide.net/doc/110x75/5f5f23468a3fea7a924cf43a/dwk-eek-v-v-v-o-o-o-l-l-.jpg)
![E } ] ( } í Ç µ v î ì î í r î ì î î](https://img.pdfslide.net/doc/110x75/61d22598186b7f513908dfef/e-v-r-.jpg)
![Z ] ] } ' } ' µ ] Ì ì ð l ì î l î ì î í](https://img.pdfslide.net/doc/110x75/621471d8662f8c0949171267/z-l-l-.jpg)
![K/ & } u h ' µ ] î ì î ì r î ì î í ] o } µ W ] } µ v } ( í](https://img.pdfslide.net/doc/110x75/62919d8e4969d411bf0bc2d4/k-amp-u-h-r-.jpg)
![> ' E ] ( µ u î Ì ] u o ] Ì Ì l o o l > ' E ] ( µ u î Ì ] u o ] Ì Ì l o o …...> ' E ] ( µ u î Ì ] u o ] Ì Ì l o o l > ' E ] ( µ u î Ì ] u o ] Ì Ì l o o l](https://img.pdfslide.net/doc/110x75/5e79aedc3a8aaf7a1b325cb8/-e-u-oe-u-o-oe-oe-l-o-o-l-e-u-oe-u-o-oe.jpg)